Marijke Valkhof

855 citations
14 papers · 516 indexed · h-index 10
Topics
Acute Myeloid Leukemia Research (4 papers)Cytokine Signaling Pathways and Interactions (3 papers)RNA modifications and cancer (2 papers)
Partner nations
NetherlandsAustriaCanada

In The Last Decade

Marijke Valkhof

14 papers receiving 511 citations

Peers

Marijke Valkhof
Comparison fields: 5 of 60
  • Immunology 250
  • Molecular Biology 204
  • Hematology 185
  • Genetics 116
  • Oncology 90
Replace Soumen Chakraborty with:
Soumen Chakraborty India
LS Rusten Norway
Riyan Chen Canada
Simon Bornschein Belgium
Deborah Clarke United Kingdom
IP Touw Netherlands
Christine Vogtenhuber United States
Jason E. Farrar United States
Joseph Suzow United States
AD Friedman United States
Marijke Valkhof relative to Soumen Chakraborty India Soumen Chakraborty's profile →
Citations per field
00.5×2.8×
Soumen Chakraborty · 1×
Citations per year

Countries citing papers authored by Marijke Valkhof

Since Specialization
Citations

This map shows the geographic impact of Marijke Valkhof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marijke Valkhof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marijke Valkhof more than expected).

Fields of papers citing papers by Marijke Valkhof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marijke Valkhof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marijke Valkhof. The network helps show where Marijke Valkhof may publish in the future.

Co-authorship network of co-authors of Marijke Valkhof

This figure shows the co-authorship network connecting the top 25 collaborators of Marijke Valkhof. A scholar is included among the top collaborators of Marijke Valkhof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marijke Valkhof. Marijke Valkhof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 37
2 125
3 6
4 22
5 125
6 2
7 1
8 47
9 24
10 14
11 2
12 22
13 35
14 54

About Marijke Valkhof

Marijke Valkhof is a scholar working on Hematology, Immunology and Developmental Neuroscience, having authored 14 papers that have together received 516 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Hematology (185 citations), Immunology (250 citations) and Genetics (60 citations). Marijke Valkhof has collaborated with scholars based in Netherlands, Austria and Canada. Frequent co-authors include Ivo P. Touw, Stefan J. Erkeland, Peter J.M. Valk, Sten F.W.M. Libregts, Martijn A. Nolte, Louis Boon, Alexander M. de Bruin, Jurgen R. Haanstra, Ruud Delwel and Renée Beekman. Their work appears in journals such as Blood, PLoS ONE and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026